A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical reviewCoutinho LFD et al. 2026 · J Sports Med Phys Fitness · DOI | CJC-1295 | Review | 2026 |
An orally active estrogen receptor-related receptor agonist, SLU-PP-915, enhances aerobic exercise capacityBillon C et al. 2026 · J Pharmacol Exp Ther · DOI | SLU-PP-332 | Mouse | 2026 |
Analysis and Identification of In Vitro Metabolites of Exercise Mimetic SLU-PP-332 ERRα/β/γ Agonist for Doping-Control PurposesAvliyakulov NK et al. 2026 · Drug Test Anal · DOI | SLU-PP-332 | Mouse | 2026 |
Efficacy and safety of once-weekly cagrilintide-semaglutide (CagriSema) in adults with type 2 diabetes inadequately controlled on diet and exercise (REIMAGINE 1): a randomised, double-blind, placebo-controlled, phase 3a studyAroda VR et al. 2026 · Lancet Diabetes Endocrinol · DOI | Cagrilintide | Human | 2026 |
Glutathione Supplementation in Parenteral Nutrition to Prevent Oxidative Stress Related Complications in Preterm Infants: A Narrative Review of Preclinical Efficacy and Safety ProfileLavoie JC et al. 2026 · Nutrients · DOI | Glutathione | Review | 2026 |
Glutathione in Skin Aging and Tissue Regeneration: A Systematic Review of Molecular Mechanisms, Redox Modulation, and Biomedical ImplicationsStanescu C et al. 2026 · Molecules · DOI | Glutathione | Review | 2026 |
In Vitro Metabolism and Analytical Characterization of SLU-PP-332 and SLU-PP-915: Novel Pan-ERR Agonists With Doping PotentialMöller T et al. 2026 · Rapid Commun Mass Spectrom · DOI | SLU-PP-332 | Analytical or other | 2026 |
Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine PhysiciansMayfield CK et al. 2026 · Am J Sports Med · DOI | GHK-Cu, CJC-1295, Ipamorelin, Tesamorelin | Review | 2026 |
KPV attenuates adipogenesis and lipid metabolism through modulation of ROS-mediated AKT/mTORC1/PPARγ signalingAn SH et al. 2026 · Tissue Cell · DOI | KPV | Mouse | 2026 |
MOTS-c improves intrinsic muscle mitochondrial bioenergetic health and efficiency in a PGC-1α/AMPK-dependent mannerGudiksen A et al. 2026 · Free Radic Biol Med · DOI | MOTS-c | Mouse | 2026 |
NAD+ precursor supplementation reverses CD36-mediated lipid accumulation and ferroptosis to restore antitumor function of NK cells in DLBCLShi L et al. 2026 · Pharm Sci Adv · DOI | NAD+ | Mouse | 2026 |
NAD+ precursor treatment prevents cardiomyopathy but disrupts erythroid maturation in mitochondrial progeriaKhan NA et al. 2026 · Cell Rep · DOI | NAD+ | Mouse | 2026 |
Novel GLP-1-based Medications for Type 2 Diabetes and ObesitySon JW et al. 2026 · Endocr Rev · DOI | Cagrilintide | Review | 2026 |
Peptide Supplements and Their Therapeutic Applications in Sports MedicineTewari K et al. 2026 · Am J Sports Med · DOI | GHK-Cu, CJC-1295, Ipamorelin | Rat | 2026 |
Retatrutide for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: Rationale and design of the TRIUMPH registrational clinical trialsGiblin K et al. 2026 · Diabetes Obes Metab · DOI | Retatrutide | Human | 2026 |
Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic PerformanceMendias CL et al. 2026 · Sports Med · DOI | AOD-9604, GHK-Cu, CJC-1295, Ipamorelin, Tesamorelin, MOTS-c | Review | 2026 |
| Synthetic Peptides in Pharmacy Compounding: Analysis of PCAC Recommendations and Industry Safety Standards Willis J et al. 2026 · Int J Pharm Compd | Epitalon | Review | 2026 |
The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administrationDominikowski A et al. 2026 · Front Endocrinol (Lausanne) · DOI | AOD-9604, IGF-1 LR3 | Review | 2026 |
Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future PerspectivesRenke G et al. 2026 · Int J Mol Sci · DOI | GHK-Cu, CJC-1295, Ipamorelin, Tesamorelin, PT-141 (bremelanotide) | Review | 2026 |
Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future DirectionsRahman OF et al. 2026 · J Am Acad Orthop Surg Glob Res Rev · DOI | AOD-9604, GHK-Cu, Ipamorelin, Tesamorelin, Selank, Semax, DSIP, Epitalon | Review | 2026 |
Therapeutic peptides in gerontology: mechanisms and applications for healthy agingMavrych V et al. 2026 · Front Aging · DOI | GHK-Cu, Ipamorelin, Semax, Epitalon, PT-141 (bremelanotide) | Review | 2026 |
Thymosin α-1 in cancer therapy: Immunomodulatory mechanisms, clinical applications, and translational perspectivesChuang SC et al. 2026 · Eur J Pharmacol · DOI | Thymosin Alpha-1 | Review | 2026 |
Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweightLook M et al. 2025 · Diabetes Obes Metab · DOI | Tirzepatide | Human | 2025 |
Cagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 DiabetesDavies MJ et al. 2025 · N Engl J Med · DOI | Cagrilintide | Human | 2025 |
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or ObesityGarvey WT et al. 2025 · N Engl J Med · DOI | Cagrilintide | Human | 2025 |
Effects of Tesamorelin on Neurocognitive Impairment in Persons With HIV and Abdominal ObesityEllis RJ et al. 2025 · J Infect Dis · DOI | Tesamorelin | Human | 2025 |
Efficacy of GLP-1 Receptor Agonist-Based Therapies on Cardiovascular Events and Cardiometabolic Parameters in Obese Individuals Without Diabetes: A Meta-Analysis of Randomized Controlled TrialsYin Y et al. 2025 · J Diabetes · DOI | Retatrutide | Review | 2025 |
Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic ReviewVasireddi N et al. 2025 · HSS J · DOI | BPC-157 | Review | 2025 |
Intranasal long R3 insulin-like growth factor-1 treatment promotes amyloid plaque remodeling in cerebral cortex but fails to preserve cognitive function in male 5XFAD miceEngel MG et al. 2025 · J Alzheimers Dis · DOI | IGF-1 LR3 | Mouse | 2025 |
Kisspeptin and neurokinin B: roles in reproductive healthKoysombat K et al. 2025 · Physiol Rev · DOI | Kisspeptin | Review | 2025 |
MOTS-c attenuates lung ischemia-reperfusion injury via MYH9-Dependent nuclear translocation and transcriptional activation of antioxidant genesLi X et al. 2025 · Redox Biol · DOI | MOTS-c | Rat | 2025 |
Multifunctional incretin peptides in therapies for type 2 diabetes, obesity and associated co-morbiditiesBailey CJ et al. 2025 · Peptides · DOI | Cagrilintide | Review | 2025 |
Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent ReviewJózwiak M et al. 2025 · Pharmaceuticals (Basel) · DOI | BPC-157 | Review | 2025 |
Novel Pharmacologic Treatments of Female Sexual DysfunctionHow A et al. 2025 · Clin Obstet Gynecol · DOI | PT-141 (bremelanotide) | Review | 2025 |
Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising PropertiesAraj SK et al. 2025 · Int J Mol Sci · DOI | Epitalon | Review | 2025 |
Polymorphism of Melanocortin Receptor Genes-Association with Inflammatory Traits and DiseasesBardhan M et al. 2025 · Diseases · DOI | Melanotan 1 (afamelanotide) | Review | 2025 |
Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal HealingMcGuire FP et al. 2025 · Curr Rev Musculoskelet Med · DOI | BPC-157 | Review | 2025 |
Retatrutide-A Game Changer in Obesity PharmacotherapyKatsi V et al. 2025 · Biomolecules · DOI | Retatrutide | Review | 2025 |
Reviving the Mitochondria: A Hopeful Horizon in Refractory Heart FailureAhmed Z et al. 2025 · Cureus · DOI | SS-31 (elamipretide) | Analytical or other | 2025 |
Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection FractionKrüger N et al. 2025 · JAMA · DOI | Tirzepatide | Human | 2025 |
Semax peptide targets the μ opioid receptor gene Oprm1 to promote deubiquitination and functional recovery after spinal cord injury in female miceLiu R et al. 2025 · Br J Pharmacol · DOI | Semax | Mouse | 2025 |
Targeting ERRs to counteract age-related muscle atrophy associated with physical inactivity: a pilot studyBonanni R et al. 2025 · Front Physiol · DOI | SLU-PP-332 | Analytical or other | 2025 |
The Potential of the Peptide Drug Semax and Its Derivative for Correcting Pathological Impairments in the Animal Model of Alzheimer's DiseaseRadchenko AI et al. 2025 · Acta Naturae · DOI | Semax | Mouse | 2025 |
Tirzepatide and cardiometabolic parameters in obesity: Summary of current evidenceSattar N et al. 2025 · Diabetes Obes Metab · DOI | Tirzepatide | Review | 2025 |
Tirzepatide for Heart Failure with Preserved Ejection Fraction and ObesityPacker M et al. 2025 · N Engl J Med · DOI | Tirzepatide | Human | 2025 |
Tirzepatide for Obesity Treatment and Diabetes PreventionJastreboff AM et al. 2025 · N Engl J Med · DOI | Tirzepatide | Human | 2025 |
Treatment Advances in Vitiligo: An Updated ReviewIsmail IB et al. 2025 · Dermatol Pract Concept · DOI | Melanotan 1 (afamelanotide) | Review | 2025 |
5-Hydroxypyrroloindoline Affords Tryptathionine and 2,2'-bis-Indole Peptide Staples: Application to Melanotan-IITodorovic M et al. 2024 · Chemistry · DOI | Melanotan II | Analytical or other | 2024 |
A Synthetic ERR Agonist Alleviates Metabolic SyndromeBillon C et al. 2024 · J Pharmacol Exp Ther · DOI | SLU-PP-332 | Mouse | 2024 |
ACTH-like Peptides Compensate Rat Brain Gene Expression Profile Disrupted by Ischemia a Day After Experimental StrokeFilippenkov IB et al. 2024 · Biomedicines · DOI | Semax | Rat | 2024 |
Cagrilintide: A Long-Acting Amylin Analog for the Treatment of ObesityD'Ascanio AM et al. 2024 · Cardiol Rev · DOI | Cagrilintide | Analytical or other | 2024 |
Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysisYao H et al. 2024 · BMJ · DOI | Cagrilintide | Review | 2024 |
Efficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and ObesityDrucker DJ 2024 · Diabetes Care · DOI | Retatrutide | Review | 2024 |
Expanded-Access Use of Elamipretide Improves Quality of Life in Patients With Rare Mitochondrial Disorders Characterized by Ophthalmic Symptoms: A Case SeriesAnsari S et al. 2024 · Clin Case Rep · DOI | SS-31 (elamipretide) | Human | 2024 |
Incretin-Based Weight Loss Pharmacotherapy: Can Resistance Exercise Optimize Changes in Body Composition?Locatelli JC et al. 2024 · Diabetes Care · DOI | Retatrutide | Review | 2024 |
Kisspeptin and Endometriosis-Is There a Link?Meczekalski B et al. 2024 · J Clin Med · DOI | Kisspeptin | Review | 2024 |
Megalin-targeting and ROS-responsive elamipretide-conjugated polymeric prodrug for treatment of acute kidney injuryHuang HL et al. 2024 · Biomed Pharmacother · DOI | SS-31 (elamipretide) | Mouse | 2024 |
Mitochondrial-Derived Peptide MOTS-c Suppresses Ovarian Cancer Progression by Attenuating USP7-Mediated LARS1 DeubiquitinationYin Y et al. 2024 · Adv Sci (Weinh) · DOI | MOTS-c | Mouse | 2024 |
Mitofilin in cardiovascular diseases: Insights into the pathogenesis and potential pharmacological interventionsChaurembo AI et al. 2024 · Pharmacol Res · DOI | SS-31 (elamipretide) | Review | 2024 |
NAD+ metabolism enzyme NNMT in cancer-associated fibroblasts drives tumor progression and resistance to immunotherapy by modulating macrophages in urothelial bladder cancerYang M et al. 2024 · J Immunother Cancer · DOI | 5-Amino-1MQ | Mouse | 2024 |
Novel Pan-ERR Agonists Ameliorate Heart Failure Through Enhancing Cardiac Fatty Acid Metabolism and Mitochondrial FunctionXu W et al. 2024 · Circulation · DOI | SLU-PP-332 | Mouse | 2024 |
Semaglutide vs Tirzepatide for Weight Loss in Adults With Overweight or ObesityRodriguez PJ et al. 2024 · JAMA Intern Med · DOI | Tirzepatide | Human | 2024 |
The bioenergetics of traumatic brain injury and its long-term impact for brain plasticity and functionThapak P et al. 2024 · Pharmacol Res · DOI | SS-31 (elamipretide) | Review | 2024 |
The power of three: Retatrutide's role in modern obesity and diabetes therapyAbdul-Rahman T et al. 2024 · Eur J Pharmacol · DOI | Retatrutide | Review | 2024 |
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trialSanyal AJ et al. 2024 · Nat Med · DOI | Retatrutide | Human | 2024 |
An evaluation of bremelanotide injection for the treatment of hypoactive sexual desire disorderCipriani S et al. 2023 · Expert Opin Pharmacother · DOI | PT-141 (bremelanotide) | Review | 2023 |
Cationic exchange SPE combined with triple quadrupole UHPLC-MS/MS for detection of GHRHs in urine samplesCristea CD et al. 2023 · Anal Biochem · DOI | CJC-1295 | Analytical or other | 2023 |
Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trialFrias JP et al. 2023 · Lancet · DOI | Cagrilintide | Human | 2023 |
Erythropoietic protoporphyria in the Netherlands: Clinical features, psychosocial impact and the effect of afamelanotideWensink D et al. 2023 · J Dermatol · DOI | Melanotan 1 (afamelanotide) | Human | 2023 |
Estrogen-Related Receptor Agonism Reverses Mitochondrial Dysfunction and Inflammation in the Aging KidneyWang XX et al. 2023 · Am J Pathol · DOI | SLU-PP-332 | Mouse | 2023 |
Liposomal Glutathione Supplementation Mitigates Extrapulmonary Tuberculosis in the Liver and SpleenSasaninia K et al. 2023 · Front Biosci (Elite Ed) · DOI | Glutathione | Mouse | 2023 |
MOTS-c Functionally Prevents Metabolic DisordersGao Y et al. 2023 · Metabolites · DOI | MOTS-c | Review | 2023 |
MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitationZheng Y et al. 2023 · Front Endocrinol (Lausanne) · DOI | MOTS-c | Review | 2023 |
Melanotan-II reverses memory impairment induced by a short-term HF dietWekwejt P et al. 2023 · Biomed Pharmacother · DOI | Melanotan II | Animal | 2023 |
NAD+ Precursors: A Physiological Reboot?Niño-Narvión J et al. 2023 · Nutrients · DOI | NAD+ | Analytical or other | 2023 |
Recombinant expression of IGF-1 and LR3 IGF-1 fused with xylanase in Pichia pastorisLu Z et al. 2023 · Appl Microbiol Biotechnol · DOI | IGF-1 LR3 | Analytical or other | 2023 |
Retatrutide showing promise in obesity (and type 2 diabetes)Doggrell SA 2023 · Expert Opin Investig Drugs · DOI | Retatrutide | Review | 2023 |
Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise CapacityBillon C et al. 2023 · ACS Chem Biol · DOI | SLU-PP-332 | Mouse | 2023 |
Targeting the central melanocortin system for the treatment of metabolic disordersSweeney P et al. 2023 · Nat Rev Endocrinol · DOI | PT-141 (bremelanotide), Melanotan 1 (afamelanotide) | Review | 2023 |
The Melanocortin System in Inflammatory Bowel Diseases: Insights into Its Mechanisms and Therapeutic PotentialsGravina AG et al. 2023 · Cells · DOI | KPV | Review | 2023 |
Thymosin alpha 1 - Reimagine its broader applications in the immuno-oncology eraMao L 2023 · Int Immunopharmacol · DOI | Thymosin Alpha-1 | Human | 2023 |
Vitiligo, from Pathogenesis to Therapeutic Advances: State of the ArtDiotallevi F et al. 2023 · Int J Mol Sci · DOI | Melanotan 1 (afamelanotide) | Review | 2023 |
Vitiligo: Pathogenesis and New and Emerging TreatmentsPerez-Bootello J et al. 2023 · Int J Mol Sci · DOI | Melanotan 1 (afamelanotide) | Review | 2023 |
CLIPSing Melanotan-II to Discover Multiple Functionally Selective hMCR AgonistsTomassi S et al. 2022 · J Med Chem · DOI | Melanotan II | Analytical or other | 2022 |
Identification of l-Tryptophan by down-field 1 H MRS: A precursor for brain NAD+ and serotonin synthesesNanga RPR et al. 2022 · Magn Reson Med · DOI | NAD+ | Human | 2022 |
Management of Hypertension with Female Sexual DysfunctionZhong Q et al. 2022 · Medicina (Kaunas) · DOI | PT-141 (bremelanotide) | Review | 2022 |
Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO miceDimet-Wiley A et al. 2022 · Sci Rep · DOI | 5-Amino-1MQ | Mouse | 2022 |
Sheep recombinant IGF-1 promotes organ-specific growth in fetal sheepStremming J et al. 2022 · Front Physiol · DOI | IGF-1 LR3 | Animal | 2022 |
Skin-adaptive film dressing with smart-release of growth factors accelerated diabetic wound healingZhao Y et al. 2022 · Int J Biol Macromol · DOI | KPV | Mouse | 2022 |
Stress, kisspeptin, and functional hypothalamic amenorrheaMeczekalski B et al. 2022 · Curr Opin Pharmacol · DOI | Kisspeptin | Review | 2022 |
The mitochondrial-derived peptide MOTS-c relieves hyperglycemia and insulin resistance in gestational diabetes mellitusYin Y et al. 2022 · Pharmacol Res · DOI | MOTS-c | Mouse | 2022 |
Tirzepatide Once Weekly for the Treatment of ObesityJastreboff AM et al. 2022 · N Engl J Med · DOI | Tirzepatide | Human | 2022 |
Advances in the detection of growth hormone releasing hormone synthetic analogsMemdouh S et al. 2021 · Drug Test Anal · DOI | CJC-1295 | Cell culture | 2021 |
Circular RNA PIP5K1A (circPIP5K1A) accelerates endometriosis progression by regulating the miR-153-3p/Thymosin Beta-4 X-Linked (TMSB4X) pathwaySun L et al. 2021 · Bioengineered · DOI | TB-500 (thymosin beta-4) | Cell culture | 2021 |
| Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain Lee E et al. 2021 · Altern Ther Health Med | BPC-157 | Human | 2021 |
Melanotan II User Experience: A Qualitative Study of Online Discussion ForumsGilhooley E et al. 2021 · Dermatology · DOI | Melanotan II | Human | 2021 |
Small molecule inhibitor of nicotinamide N-methyltransferase shows anti-proliferative activity in HeLa cellsAkar S et al. 2021 · J Obstet Gynaecol · DOI | 5-Amino-1MQ | Cell culture | 2021 |
Stable Gastric Pentadecapeptide BPC 157 and Wound HealingSeiwerth S et al. 2021 · Front Pharmacol · DOI | BPC-157 | Review | 2021 |
Tesamorelin improves fat quality independent of changes in fat quantityLake JE et al. 2021 · AIDS · DOI | Tesamorelin | Human | 2021 |
The effects of 3 weeks of oral glutathione supplementation on whole body insulin sensitivity in obese males with and without type 2 diabetes: a randomized trialSøndergård SD et al. 2021 · Appl Physiol Nutr Metab · DOI | Glutathione | Human | 2021 |
Thymosin beta-4 prenatal administration improves fetal development and halts side effects due to preterm deliveryFaa G et al. 2021 · Eur Rev Med Pharmacol Sci · DOI | TB-500 (thymosin beta-4) | Mouse | 2021 |
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 DiabetesFrías JP et al. 2021 · N Engl J Med · DOI | Tirzepatide | Human | 2021 |
BPC 157 Rescued NSAID-cytotoxicity Via Stabilizing Intestinal Permeability and Enhancing CytoprotectionPark JM et al. 2020 · Curr Pharm Des · DOI | BPC-157 | Review | 2020 |
Bremelanotide: New Drug Approved for Treating Hypoactive Sexual Desire DisorderMayer D et al. 2020 · Ann Pharmacother · DOI | PT-141 (bremelanotide) | Review | 2020 |
Functional Connectomic Approach to Studying Selank and Semax EffectsPanikratova YR et al. 2020 · Dokl Biol Sci · DOI | Selank, Semax | Human | 2020 |
Glutathione Supplementation as an Adjunctive Therapy in COVID-19Guloyan V et al. 2020 · Antioxidants (Basel) · DOI | Glutathione | Review | 2020 |
Melanotan II: a possible cause of renal infarction: review of the literature and case reportPeters B et al. 2020 · CEN Case Rep · DOI | Melanotan II | Review | 2020 |
Metabolic regulation of kisspeptin - the link between energy balance and reproductionNavarro VM 2020 · Nat Rev Endocrinol · DOI | Kisspeptin | Review | 2020 |
A PepT1 mediated medicinal nano-system for targeted delivery of cyclosporine A to alleviate acute severe ulcerative colitisWu Y et al. 2019 · Biomater Sci · DOI | KPV | Mouse | 2019 |
Are melanocortin peptides future therapeutics for cutaneous wound healing?Böhm M et al. 2019 · Exp Dermatol · DOI | KPV | Mouse | 2019 |
Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healingGwyer D et al. 2019 · Cell Tissue Res · DOI | BPC-157 | Review | 2019 |
Inhibition of activin-like kinase 4/5 attenuates cancer cachexia associated muscle wastingLevolger S et al. 2019 · Sci Rep · DOI | IGF-1 LR3 | Mouse | 2019 |
Kisspeptin and Glucose HomeostasisIzzi-Engbeaya C et al. 2019 · Semin Reprod Med · DOI | Kisspeptin | Review | 2019 |
Kisspeptin and ProlactinGrattan DR et al. 2019 · Semin Reprod Med · DOI | Kisspeptin | Mouse | 2019 |
State of Colon Microbiota in Rats during Chronic Restraint Stress and Selank TreatmentMukhina AY et al. 2019 · Bull Exp Biol Med · DOI | Selank | Rat | 2019 |
The mitochondria-targeting peptide elamipretide diminishes circulating HtrA2 in ST-segment elevation myocardial infarctionHortmann M et al. 2019 · Eur Heart J Acute Cardiovasc Care · DOI | SS-31 (elamipretide) | Human | 2019 |
| A glimpse into the underground market of melanotan Callaghan Iii DJ 2018 · Dermatol Online J | Melanotan 1 (afamelanotide) | Human | 2018 |
Erratum: Author Correction: Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled studyDellinger RW et al. 2018 · NPJ Aging Mech Dis · DOI | NAD+ | Analytical or other | 2018 |
Mitochondrial regulation of diabetic vascular disease: an emerging opportunityWidlansky ME et al. 2018 · Transl Res · DOI | SS-31 (elamipretide) | Review | 2018 |
Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological ActivityVyunova TV et al. 2018 · Protein Pept Lett · DOI | Selank | Rat | 2018 |
Pharmacological Aspects of Neuro-Immune InteractionsTarasov VV et al. 2018 · Curr Pharm Des · DOI | Semax | Review | 2018 |
Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene DataPickart L et al. 2018 · Int J Mol Sci · DOI | GHK-Cu | Review | 2018 |
Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in miceNeelakantan H et al. 2018 · Biochem Pharmacol · DOI | 5-Amino-1MQ | Mouse | 2018 |
GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 CellsFilatova E et al. 2017 · Front Pharmacol · DOI | Selank | Analytical or other | 2017 |
Noncoupled Fluorescent Assay for Direct Real-Time Monitoring of Nicotinamide N-Methyltransferase ActivityNeelakantan H et al. 2017 · Biochemistry · DOI | 5-Amino-1MQ | Analytical or other | 2017 |
Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in RatsKasian A et al. 2017 · Behav Neurol · DOI | Selank | Rat | 2017 |
Potential role of thymosin beta 4 in the treatment of nonalcoholic fatty liver diseaseJiang Y et al. 2017 · Chronic Dis Transl Med · DOI | TB-500 (thymosin beta-4) | Review | 2017 |
SIRT1 and NAD+ precursors: Therapeutic targets in multiple sclerosis a reviewNimmagadda VK et al. 2017 · J Neuroimmunol · DOI | NAD+ | Review | 2017 |
Targeting Metabolic Modulation and Mitochondrial Dysfunction in the Treatment of Heart FailureSteggall A et al. 2017 · Diseases · DOI | SS-31 (elamipretide) | Review | 2017 |
Tuftsin - Properties and AnalogsSiebert A et al. 2017 · Curr Med Chem · DOI | Selank | Review | 2017 |
Simplifying and expanding the screening for peptides <2 kDa by direct urine injection, liquid chromatography, and ion mobility mass spectrometryThomas A et al. 2016 · J Sep Sci · DOI | AOD-9604 | Analytical or other | 2016 |
Dual effect of Thymosin α 1 on human monocyte-derived dendritic cell in vitro stimulated with viral and bacterial toll-like receptor agonistsGiacomini E et al. 2015 · Expert Opin Biol Ther · DOI | Thymosin Alpha-1 | Cell culture | 2015 |
GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin RegenerationPickart L et al. 2015 · Biomed Res Int · DOI | GHK-Cu | Review | 2015 |
Peptides and the blood-brain barrierBanks WA 2015 · Peptides · DOI | DSIP | Review | 2015 |
The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistanceLee C et al. 2015 · Cell Metab · DOI | MOTS-c | Mouse | 2015 |
Thymosin alpha-1 treatment in chronic hepatitis BWu X et al. 2015 · Expert Opin Biol Ther · DOI | Thymosin Alpha-1 | Human | 2015 |
Analytical approaches for the detection of emerging therapeutics and non-approved drugs in human doping controlsThevis M et al. 2014 · J Pharm Biomed Anal · DOI | AOD-9604 | Review | 2014 |
Detecting peptidic drugs, drug candidates and analogs in sports doping: current status and future directionsThevis M et al. 2014 · Expert Rev Proteomics · DOI | AOD-9604 | Animal | 2014 |
| Influence of the GPX1 gene polymorphism to aerobic capacity and efficiency of glutathione supplementation in athletes Lifanov AD et al. 2014 · Ross Fiziol Zh Im I M Sechenova | Glutathione | Analytical or other | 2014 |
NAD(+) supplementation as a novel approach to cURIng HCC?Mederacke I et al. 2014 · Cancer Cell · DOI | NAD+ | Animal | 2014 |
The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysisMedvedeva EV et al. 2014 · BMC Genomics · DOI | Semax | Rat | 2014 |
Immunoreactivity for thymosin beta 4 and thymosin beta 10 in the adult rat oro-gastro-intestinal tractNemolato S et al. 2013 · Eur J Histochem · DOI | TB-500 (thymosin beta-4) | Rat | 2013 |
Kisspeptin antagonistsRoseweir AK et al. 2013 · Adv Exp Med Biol · DOI | Kisspeptin | Review | 2013 |
Modulation of body temperature and LH secretion by hypothalamic KNDy (kisspeptin, neurokinin B and dynorphin) neurons: a novel hypothesis on the mechanism of hot flushesRance NE et al. 2013 · Front Neuroendocrinol · DOI | Kisspeptin | Review | 2013 |
Antibodies in research of thymosin β4: investigation of cross-reactivity and influence of fixativesKnop J et al. 2012 · Ann N Y Acad Sci · DOI | TB-500 (thymosin beta-4) | Analytical or other | 2012 |
Efficacy of ipamorelin, a ghrelin mimetic, on gastric dysmotility in a rodent model of postoperative ileusGreenwood-Van Meerveld B et al. 2012 · J Exp Pharmacol · DOI | Ipamorelin | Rat | 2012 |
Melanotan II injection resulting in systemic toxicity and rhabdomyolysisNelson ME et al. 2012 · Clin Toxicol (Phila) · DOI | Melanotan II | Human | 2012 |
A sucrose-derived scaffold for multimerization of bioactive peptidesRao V et al. 2011 · Bioorg Med Chem · DOI | KPV | Cell culture | 2011 |
Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNAFedoreyeva LI et al. 2011 · Biochemistry (Mosc) · DOI | Epitalon | Cell culture | 2011 |
Tesamorelin: a review of its use in the management of HIV-associated lipodystrophyDhillon S 2011 · Drugs · DOI | Tesamorelin | Review | 2011 |
Detection of His-tagged Long-R³-IGF-I in a black market productKohler M et al. 2010 · Growth Horm IGF Res · DOI | IGF-1 LR3 | Analytical or other | 2010 |
The effect of antioxidant supplementation on fatigue during exercise: potential role for NAD+(H)Mach J et al. 2010 · Nutrients · DOI | NAD+ | Human | 2010 |
Melanocortins in the treatment of male and female sexual dysfunctionShadiack AM et al. 2007 · Curr Top Med Chem · DOI | PT-141 (bremelanotide) | Review | 2007 |
Efficacy of thymosin alpha-1 and interferon alpha in treatment of chronic viral hepatitis B: a randomized controlled studyYou J et al. 2006 · World J Gastroenterol · DOI | Thymosin Alpha-1 | Human | 2006 |
Melanotan-II: Investigation of the inducer and facilitator effects on penile erection in anaesthetized ratGiuliano F et al. 2006 · Neuroscience · DOI | Melanotan II | Rat | 2006 |
Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adultsTeichman SL et al. 2006 · J Clin Endocrinol Metab · DOI | CJC-1295 | Human | 2006 |
Insulin-like growth factor binding protein (IGFBP)-3 and IGFBP-5 mediate TGF-beta- and myostatin-induced suppression of proliferation in porcine embryonic myogenic cell culturesKamanga-Sollo E et al. 2005 · Exp Cell Res · DOI | IGF-1 LR3 | Animal | 2005 |
| Triple combination of thymalfasin, peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior interferon and ribavirin treatment: 24-week interim results of a pilot study Poo JL et al. 2004 · J Gastroenterol Hepatol | Thymosin Alpha-1 | Human | 2004 |
Triple combination of thymalfasin, peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior interferon and ribavirin treatment: 24-week interim results of a pilot studyPoo JL et al. 2004 · J Gastroenterol Hepatol · DOI | Thymosin Alpha-1 | Human | 2004 |
Blood albumin in the mechanisms of individual resistance of rats to emotional stressKoplik EV et al. 2003 · Neurosci Behav Physiol · DOI | DSIP | Rat | 2003 |
Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growthStaresinic M et al. 2003 · J Orthop Res · DOI | BPC-157 | Rat | 2003 |
Retinoprotective effect of Epithalon in campbell rats of various agesKhavinson VKh et al. 2003 · Bull Exp Biol Med · DOI | Epitalon | Rat | 2003 |
Insulin-like growth factor binding protein-2 mediates the inhibition of DNA synthesis by transforming growth factor-beta in mink lung epithelial cellsDong F et al. 2002 · J Cell Physiol · DOI | IGF-1 LR3 | Animal | 2002 |
| Peptides and Ageing Khavinson VKh 2002 · Neuro Endocrinol Lett | Epitalon | Review | 2002 |
The inhibitory effect of Selank on enkephalin-degrading enzymes as a possible mechanism of its anxiolytic activityZozulya AA et al. 2001 · Bull Exp Biol Med · DOI | Selank | Human | 2001 |
Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormoneNg FM et al. 2000 · Horm Res · DOI | AOD-9604 | Rat | 2000 |
Ipamorelin, the first selective growth hormone secretagogueRaun K et al. 1998 · Eur J Endocrinol · DOI | Ipamorelin | Rat | 1998 |
Highly increased levels of active stromelysin in rheumatoid synovial fluid determined by a selective fluorogenic assayBeekman B et al. 1997 · FEBS Lett · DOI | KPV | Human | 1997 |
| Neuropeptides and human sleep Steiger A et al. 1997 · Sleep | DSIP | Review | 1997 |
| The effect of acute glutathione treatment on sorbitol level in erythrocytes from diabetic patients Ciuchi E et al. 1997 · Diabetes Metab | Glutathione | Human | 1997 |
Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical studyDorr RT et al. 1996 · Life Sci · DOI | Melanotan II | Human | 1996 |
Reduced intravenous glutathione in the treatment of early Parkinson's diseaseSechi G et al. 1996 · Prog Neuropsychopharmacol Biol Psychiatry · DOI | Glutathione | Human | 1996 |
The immunosuppressive mini-domain of human lactoferrinSiemion IZ et al. 1995 · J Pept Sci · DOI | KPV | Mouse | 1995 |
Effects of delta sleep-inducing peptide on sleep of chronic insomniac patients. A double-blind studyBes F et al. 1992 · Neuropsychobiology · DOI | DSIP | Human | 1992 |
HPA-related CSF neuropeptides in suicide attemptersTräskman-Bendz L et al. 1992 · Eur Neuropsychopharmacol · DOI | DSIP | Human | 1992 |
Immunohistochemical localization of delta sleep-inducing peptide-like immunoreactivity in the central nervous system and pituitary of the frog Rana ridibundaYon L et al. 1992 · Neuroscience · DOI | DSIP | Animal | 1992 |
| Serum levels of immunoreactive thymosin alpha 1 and thymosin beta 4 in large cohorts of healthy adults Weller FE et al. 1992 · Thymus | TB-500 (thymosin beta-4) | Human | 1992 |
Thymosin alpha 1 and thymosin beta 4 modulate human colonic lamina propria lymphocyte functionElitsur Y et al. 1990 · Immunopharmacology · DOI | Thymosin Alpha-1 | Cell culture | 1990 |
Characterization of secretion of thymosin alpha 1 and thymosin beta 4 during prepuberty, estrus and pregnancy in the bovine femaleWolfe MW et al. 1989 · Domest Anim Endocrinol · DOI | TB-500 (thymosin beta-4) | Animal | 1989 |
| Enzyme immunoassay measurement of thymosin beta 4 in human serum Weller FE et al. 1988 · J Biol Response Mod | TB-500 (thymosin beta-4) | Animal | 1988 |
DSIP reduces amphetamine-induced hyperthermia in miceGraf MV et al. 1984 · Physiol Behav · DOI | DSIP | Mouse | 1984 |